Investor

BIO-Europe Spring

Name: BIO-Europe Spring
Start: 2027-03-22
Location: Rotating

Europe's premier springtime biotechnology partnering conference, connecting global life science companies with early stage investors.

When: March, Mid March
Where: RotatingView on Google Maps
Format: In person
Organiser: EBD Group
Region: Europe
Scale: About 3,500 attendees
Founded: 2007

The Signal

BIO-Europe Spring is the primary spring-season biotechnology partnering conference in Europe, organized by the EBD Group. It provides a dedicated marketplace for life science companies, biotechnology firms, and institutional investors to negotiate licensing deals and capital injections. The conference focuses on early-to-mid-stage biotechnology innovations, clinical research pipelines, and computational drug discovery platforms. For healthtech operators in the life sciences space, it is a highly transactional event focused on structured one-on-one meetings.

What to expect

Biotech asset licensing deals
Pre-clinical development collaboration announcements
Early-stage venture capital funding agreements
Therapeutic research platform partnerships

Who is in the room

Biotech entrepreneurs, pharmaceutical business development executives, venture capitalists, and academic spin-out founders attend.

Background

BIO-Europe Spring was established in 2007 as a sister event to the larger autumn BIO-Europe conference. It was created to meet year-round industry demand for structured partnering in Europe's growing life science sector.

Official event site